Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bojarska-Dahlig

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|October 1, 1971
Trends in antibiotic researchH Bojarska-Dahlig
The Journal of Antimicrobial Chemotherapy|March 1, 1990
Hepatotoxicity of macrolide antibioticsH Bojarska-Dahlig
The Journal of Antibiotics|May 1, 1978
A C-13 relaxation study on erythromycin A cyclic 11,12-carbonateA Neszmélyi, H Bojarska-Dahlig
Polish Journal of Pharmacology and Pharmacy|October 1, 1981
Quantitative structure-activity relationships in erythromycin group with MTD techniqueH Bojarska-Dahlig, Z Simon, T Głabski
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|May 22, 1978
[Effectiveness of L-aspartate of erythromycin A cyclic carbonate, a new Polish semisynthetic antibiotic in systemic infections caused by staphylococci and in pneumococcal pneumonia in mice]R Kadłubowski, A Kurnatowska, H Bojarska-Dahlig
Acta Poloniae Pharmaceutica|January 1, 1975
[Salts of cyclic erythromycin A carbonate with cinnamic acid derivatives]H Bojarska-Dahlig, T Gloabski, I Dzioegielewska
Acta Poloniae Pharmaceutica|January 1, 1974
[Some biological properties the cyclic carbonate of erythromycin A]W Chojnowski, A Zaremba, H Bojarska-Dahlig
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|May 27, 1985
[Antitubercular properties of erythromycin A cyclic 11,12-carbonate in experiments in vitro and in vivo]M Janowiec, J Marczewska, A Stambrowska, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|January 1, 1982
Some toxicological aspects of Davercin (cyclic 11,12-carbonate of erythromycin A) application in dogsR Fitko, A Zasadowski, R Faundez, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|January 1, 1982
Chemical modifications in the erythromycin group leading to an increase of the antibacterial activityH Bojarska-Dahlig, W Sławiński, W Chojnowski, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|October 1, 1971
Trends in antibiotic researchH Bojarska-Dahlig
The Journal of Antimicrobial Chemotherapy|March 1, 1990
Hepatotoxicity of macrolide antibioticsH Bojarska-Dahlig
The Journal of Antibiotics|May 1, 1978
A C-13 relaxation study on erythromycin A cyclic 11,12-carbonateA Neszmélyi, H Bojarska-Dahlig
Polish Journal of Pharmacology and Pharmacy|October 1, 1981
Quantitative structure-activity relationships in erythromycin group with MTD techniqueH Bojarska-Dahlig, Z Simon, T Głabski
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|May 22, 1978
[Effectiveness of L-aspartate of erythromycin A cyclic carbonate, a new Polish semisynthetic antibiotic in systemic infections caused by staphylococci and in pneumococcal pneumonia in mice]R Kadłubowski, A Kurnatowska, H Bojarska-Dahlig
Acta Poloniae Pharmaceutica|January 1, 1975
[Salts of cyclic erythromycin A carbonate with cinnamic acid derivatives]H Bojarska-Dahlig, T Gloabski, I Dzioegielewska
Acta Poloniae Pharmaceutica|January 1, 1974
[Some biological properties the cyclic carbonate of erythromycin A]W Chojnowski, A Zaremba, H Bojarska-Dahlig
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|May 27, 1985
[Antitubercular properties of erythromycin A cyclic 11,12-carbonate in experiments in vitro and in vivo]M Janowiec, J Marczewska, A Stambrowska, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|January 1, 1982
Some toxicological aspects of Davercin (cyclic 11,12-carbonate of erythromycin A) application in dogsR Fitko, A Zasadowski, R Faundez, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|January 1, 1982
Chemical modifications in the erythromycin group leading to an increase of the antibacterial activityH Bojarska-Dahlig, W Sławiński, W Chojnowski, et al.
Pageof 2